BioSpace News Archive

With the completion of SURE’s recent $1.5M seed financing, SURE has appointed its lead investor, Vince Proffitt, owner and operator of Spartan Medical to its Board of Directors.

Ocugen, Inc. announced that the Company was informed by the U.S. Food and Drug Administration (FDA) that the agency placed its Phase 2/3 immuno-bridging and broadening study for COVAXIN™ (BBV152), OCU-002, on clinical hold.

EV Biologics Corp, OTC PINK:YECO, announced that it has succeeded in isolating primary progenitor cells from tissue using a xeno-free process.

Renovion announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief Medical Officer.

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biopharmaceutical company, announced today that the abstract has been accepted for an Oral Proffered Paper at the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) 2022 annual meeting, which will be held in hybrid on June 23-25, 2022 in Toronto, Canada.

Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased to announce that David Sharp has joined Catalyst as Vice President of Global Marketing effective immediately.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), today highlights three posters presented during the American Association of Cancer Research (AACR) held in New Orleans from April 8-13, 2022.

The advancement in the field of clinical research has led to identification of several oncogenes which are generally mutated in cancers.

Shoreline Biosciences, Inc. (Shoreline), today announced the presentation of data at the American Association for Cancer Research (AACR) annual meeting in New Orleans, LA, taking place from April 8-13, 2022.

Adam Clarke, CEO and Principal Consultant of Stratus commented, “The projects that Nirvana Life Sciences are advancing represent the evolution of modern medicine.